osimertinib
astrazeneca
['adaura', 'osimertinib', 'aura ,(-laura)']
3. #asco23 update: an extra 2-year follow-up in the adaura study reveals adjuvant osimertinib's sustained benefits. stage ib iiia dfs hr was 0.27. progress in action! #cancerresearch #science
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer